Recently, the prognostic role of NCL has been reported in pediatric intracranial ependymoma, cutaneous melanocytic lesions and gastric cancer tissues, in which nuclear NCL overexpression is associated with the tumour progression of pediatric ependymoma, melanoma and gastric cancer [33–35]. This evidence concerns the gene NUCLEOLIN and gastric cancer.